Filing metadata

Accession number
0000899243-21-034290
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Aug 26, 2021
Reporting period
Aug 17, 2021
Description
Insider transaction

Explore SEC Filings Hub